Stock Events

Stock Events

Codexis 

$1.6000
63
+$0.10+6.67% 20:00 Today
-$0.01-0.72%22:23After hours

Statistics

Day High
1.65
Day Low
1.52
52W High
3.06
52W Low
0.96
Volume
1,862,145
Avg. Volume
1,110,504
Mkt Cap
175.21M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.25
-0.18
-0.11
-0.04
Expected EPS
-0.098333
Actual EPS
N/A

Financials

-62.47%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
70.39MRevenue
-43.97MNet Income

Analyst Ratings

8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDXS. It's not an investment recommendation.
Palantir Technologies
11
PLTR
Microsoft
10
MSFT
Tesla
10
TSLA
Amazon
10
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zymeworks BC
ZYME
Mkt Cap1.78B
Zymeworks Inc. is involved in the development of biotherapeutics, competing with Codexis in the biocatalyst market for pharmaceuticals.
Evotec
EVO
Mkt Cap696.56M
Evogene Ltd. focuses on the development of products for various life science markets, including the use of computational predictive biology, overlapping with Codexis' enzyme optimization technologies.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap289.65M
Koninklijke DSM N.V. is a global science-based company active in health, nutrition, and materials, including biotechnology solutions that compete with Codexis' offerings.
Novonesis AS
NVZMY
Mkt Cap30.33B
Novozymes A/S is a world leader in bioinnovation and industrial enzymes, directly competing with Codexis in the development and production of novel enzymes.
DuPont de Nemours
DD
Mkt Cap19.75B
DuPont de Nemours, Inc. offers technology-based materials, ingredients, and solutions, including biotechnology products that compete with Codexis in the industrial biotech space.
Symrise
SYIEY
Mkt Cap14.21B
Symrise AG is engaged in producing flavors and fragrances, enzymes, and cosmetic ingredients, competing with Codexis in the specialty enzymes market.

About

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Show more...
CEO
Alison Moore
Employees
146
Country
United States
ISIN
US1920051067
WKN
000A0Q2S4

Listings

STU
DE
4QK.STU
F
DE
4QK.F
BOATS
BOATS
CDXS.BOATS
MU
DE
4QK.MU

0 Comments

Share your thoughts

FAQ

What is Codexis stock price today?▼
The current price of CDXS is $1.60 USD — it has increased by +6.67% in the past 24 hours. Watch Codexis stock price performance more closely on the chart.
What is Codexis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Codexis stocks are traded under the ticker CDXS.
Is Codexis stock price growing?▼
CDXS stock has risen by +0% compared to the previous week, the month change is a -28.57% fall, over the last year Codexis has showed a -44.25% decrease.
What is Codexis market cap?▼
Today Codexis has the market capitalization of 175.21M
When is the next Codexis earnings date?▼
Codexis is going to release the next earnings report on October 29, 2026.
What were Codexis earnings last quarter?▼
CDXS earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.14 USD resulting in a +8.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Codexis revenue for the last year?▼
Codexis revenue for the last year amounts to 70.39M USD.
What is Codexis net income for the last year?▼
CDXS net income for the last year is -43.97M USD.
How many employees does Codexis have?▼
As of August 19, 2026, the company has 146 employees.
In which sector is Codexis located?▼
Codexis operates in the Health & Wellness sector.
When did Codexis complete a stock split?▼
Codexis has not had any recent stock splits.
Where is Codexis headquartered?▼
Codexis is headquartered in REDWOOD CITY, United States.